Business
Microbix & ACPCC support efforts to eliminate cervical cancer in the Indo-Pacific
MISSISSAUGA, Ontario and MELBOURNE, Australia, March 17, 2025 (GLOBE NEWSWIRE) -- Microbix Biosys...
About this update from Microbix Biosystems Inc.
[{"type":"text","content":"Microbix & ACPCC support efforts to eliminate cervical cancer in the Indo-PacificEPICC HPV Elimination Partnership being supplied PROCEEDxFLOQ QAPs to Support Test Accuracy\n\n\n\n MISSISSAUGA, Ontario and MELBOURNE, Australia, March 17, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (\n \n TSX: MBX, OTCQX: MBXBF, Microbix\n \n ®\n \n\n ), a life sciences innovator, manufacturer, and exporter, and the Australian Centre for the Prevention of Cervical Cancer (\n \n ACPCC\n \n ) with its Australian HPV Reference Laboratory, announce that they have signed a Memorandum Of Understanding (\n \n MOU\n \n ) under which Microbix will supply its PROCEEDx™FLOQ\n \n ®\n \n brand Quality Assessment Products (\n \n QAPs™\n \n ) to support quality management of testing for high-risk Human Papillomavirus (\n \n HPV\n \n ) infections, which cause most cases of cervical cancer. The MOU signing took place in Microbix’s exhibition booth at the 30\n \n th\n \n annual congress of the European Research Organization on Genital Infection and Neoplasia (\n \n EUROGIN 2025\n \n ) in Porto, Portugal (March 16-19 2025).\n \n\n The ACPCC is part of an established consortium, delivering a program called the Elimination Partnership in the Indo-Pacific for Cervical Cancer (\n \n EPICC\n \n ), with support from the Australian Government and philanthropic partners. The consortium delivering EPICC and its affiliated programs aims to improve the prevention, diagnosis, and treatment of cervical cancer in the Indo-Pacific – working toward the elimination of this largely preventable disease that continues to be a major health crisis in the region.\n \n\n EPICC is a humanitarian and market-shaping program – the underlying model having already been proven in countries such as Malaysia, Papua New Guinea, Vanuatu and Tuvalu. Together with affiliate programs, this phase is extending the EPICC model to add Timor-Leste, Solomon Islands, Kiribati, The Republic of the Marshall Islands, Samoa, Tonga, Fiji and Nauru – for a total of 12 Indo-Pacific nations.\n \n\n Associate Professor David Hawkes, Director of Medical Microbiology at ACPCC, stated that, “Cervical cancer is preventable by vaccination and HPV screening, but remains a leading cause of death for women in the Indo-Pacific. EPICC aims to reduce the human toll...